These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1509507)
21. Use of an optimized in vitro lymphocyte blastogenesis assay to detect contact sensitivity to nickel sulfate in mice. Robinson MK; Sneller DL Toxicol Appl Pharmacol; 1990 Jun; 104(1):106-16. PubMed ID: 1694310 [TBL] [Abstract][Full Text] [Related]
22. Assessment of metal sensitizer potency with the reconstructed human epidermis IL-18 assay. Gibbs S; Kosten I; Veldhuizen R; Spiekstra S; Corsini E; Roggen E; Rustemeyer T; Feilzer AJ; Kleverlaan CJ Toxicology; 2018 Jan; 393():62-72. PubMed ID: 29079364 [TBL] [Abstract][Full Text] [Related]
23. Increased cell proliferation in spleen and lymph nodes peripheral to contact allergen application site. Chipinda I; Anderson SE; Butterworth LF; Beezhold D; Siegel PD Toxicology; 2009 Mar; 257(3):113-6. PubMed ID: 19150643 [TBL] [Abstract][Full Text] [Related]
24. Identification of metal allergens in the local lymph node assay. Basketter DA; Lea LJ; Cooper KJ; Ryan CA; Gerberick GF; Dearman RJ; Kimber I Am J Contact Dermat; 1999 Dec; 10(4):207-12. PubMed ID: 10594296 [TBL] [Abstract][Full Text] [Related]
25. Patch testing with hexavalent chromium salts in different vehicles and with nickel and cobalt in petrolatum. Samsoen M; Stampf JL; Lelièvre G; Foussereau J Derm Beruf Umwelt; 1982; 30(6):181-4. PubMed ID: 6218976 [TBL] [Abstract][Full Text] [Related]
26. Improved ex vivo/in vitro lymph node cell proliferation assay in guinea pigs for a screening test of contact hypersensitivity of chemical compounds. Kashima R; Oyake Y; Okada J; Ikeda Y Toxicology; 1996 Nov; 114(1):47-55. PubMed ID: 8931760 [TBL] [Abstract][Full Text] [Related]
27. Development of a non-radioactive endpoint in a modified local lymph node assay. Hariya T; Hatao M; Ichikawa H Food Chem Toxicol; 1999 Jan; 37(1):87-93. PubMed ID: 10069486 [TBL] [Abstract][Full Text] [Related]
28. Local lymph node activation and IgE responses in brown Norway and Wistar rats after dermal application of sensitizing and non-sensitizing chemicals. Arts JH; Dröge SC; Spanhaak S; Bloksma N; Penninks AH; Kuper CF Toxicology; 1997 Feb; 117(2-3):229-34. PubMed ID: 9057902 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive effects of clonidine on the induction of contact sensitization in the balb/c mouse. Robinson MK; Sozeri TJ J Invest Dermatol; 1990 Nov; 95(5):587-91. PubMed ID: 2230222 [TBL] [Abstract][Full Text] [Related]
30. A preliminary evaluation of immune stimulation following exposure to metal particles and ions using the mouse popliteal lymph node assay. Tvermoes BE; Unice KM; Winans B; Kovochich M; Christian WV; Donovan E; Fung ES; Finley BL; Kimber I; Paustenbach DJ Toxicol Appl Pharmacol; 2016 Oct; 308():77-90. PubMed ID: 27478144 [TBL] [Abstract][Full Text] [Related]
31. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Kimber I; Hilton J; Dearman RJ; Gerberick GF; Ryan CA; Basketter DA; Scholes EW; Ladics GS; Loveless SE; House RV Toxicology; 1995 Nov; 103(1):63-73. PubMed ID: 8525491 [TBL] [Abstract][Full Text] [Related]
32. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals. Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862 [TBL] [Abstract][Full Text] [Related]
33. The local lymph node assay (LLNA). Rovida C; Ryan C; Cinelli S; Basketter D; Dearman R; Kimber I Curr Protoc Toxicol; 2012 Feb; Chapter 20():Unit 20.7. PubMed ID: 22511117 [TBL] [Abstract][Full Text] [Related]
34. Prediction of drug allergenicity: possible use of the local lymph node assay. Warbrick EV; Dearman RJ; Kimber I Curr Opin Drug Discov Devel; 2001 Jan; 4(1):60-5. PubMed ID: 11727324 [TBL] [Abstract][Full Text] [Related]
35. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay. Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759 [TBL] [Abstract][Full Text] [Related]
36. The local lymph node assay and potential application to the identification of drug allergens. Kimber I Toxicology; 2001 Feb; 158(1-2):59-64. PubMed ID: 11164993 [TBL] [Abstract][Full Text] [Related]
37. Contact allergenic potency: correlation of human and local lymph node assay data. Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521 [TBL] [Abstract][Full Text] [Related]
38. Human potency predictions for aldehydes using the local lymph node assay. Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison. Piccotti JR; Knight SA; Gillhouse K; Lagattuta MS; Bleavins MR J Appl Toxicol; 2006; 26(4):333-40. PubMed ID: 16705757 [TBL] [Abstract][Full Text] [Related]
40. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4. Vandebriel RJ; De Jong WH; Spiekstra SW; Van Dijk M; Fluitman A; Garssen J; Van Loveren H Toxicol Appl Pharmacol; 2000 Jan; 162(2):77-85. PubMed ID: 10637130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]